Clinical Trial Update: ApoA-I Synthesis Stimulation and Intravascular Ultrasound for Coronary Atheroma Regression Evaluation [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating ApoA-I synthesis stimulation with intravascular ultrasound to assess regression of coronary atheroma in coronary artery diseas…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• RVX-208 (apolipoprotein A-I synthesis stimulator)

Snippet

Sponsor: Resverlogix Corp | Conditions: Coronary Artery Disease | Phase 2 | Status: COMPLETED